Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis.

Jodeleit H, Milchram L, Soldo R, Beikircher G, Schönthaler S, Al-Amodi O, Wolf E, Beigel F, Weinhäusel A, Siebeck M, Gropp R.

PLoS One. 2020 Feb 12;15(2):e0228615. doi: 10.1371/journal.pone.0228615. eCollection 2020.


The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.

Jodeleit H, Caesar J, Villarroel Aguilera C, Sterz S, Holdt L, Beigel F, Stallhofer J, Breiteneicher S, Bartnik E, Siebeck M, Gropp R.

Inflamm Bowel Dis. 2019 Nov 29. pii: izz284. doi: 10.1093/ibd/izz284. [Epub ahead of print]


Targeting ulcerative colitis by suppressing glucose uptake with ritonavir.

Jodeleit H, Al-Amodi O, Caesar J, Villarroel Aguilera C, Holdt L, Gropp R, Beigel F, Siebeck M.

Dis Model Mech. 2018 Nov 21;11(11). pii: dmm036210. doi: 10.1242/dmm.036210.


CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.

Al-Amodi O, Jodeleit H, Beigel F, Wolf E, Siebeck M, Gropp R.

Inflamm Bowel Dis. 2018 May 17. doi: 10.1093/ibd/izy073. [Epub ahead of print]


Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model.

Jodeleit H, Palamides P, Beigel F, Mueller T, Wolf E, Siebeck M, Gropp R.

J Transl Med. 2017 Dec 28;15(1):265. doi: 10.1186/s12967-017-1368-4.


A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals.

Palamides P, Jodeleit H, Föhlinger M, Beigel F, Herbach N, Mueller T, Wolf E, Siebeck M, Gropp R.

Dis Model Mech. 2016 Sep 1;9(9):985-97. doi: 10.1242/dmm.025452. Epub 2016 Aug 4.

Supplemental Content

Loading ...
Support Center